Generics
ImmunityBio, NantKwest Ink COVID-19 Joint Development, Manufacturing and Marketing Agreement
28 May 2020 - - US-based clinical-stage, natural killer cell-based therapeutics company NantKwest, Inc. (NASDAQ: NK) and US-based immunotherapy company ImmunityBio have signed a binding term sheet to ...
Mayne Pharm reports availability of BAC 300 capsules in US migraine market
22 May 2020 - Pharmaceutical company Mayne Pharma Group Limited (ASX:MYX) said on Thursday that it has launched its butalbital acetaminophen and caffeine (BAC) capsule in 50mg/300mg/40mg in the United...
Hikma wins US FDA approval for generic Vascepa for the heart
22 May 2020 - Generic pharmaceutical company Hikma Pharmaceuticals plc (LSE:HIK) (NASDAQ Dubai:HIK) (OTC:HKMPY) reported on Thursday that its wholly owned US subsidiary Hikma Pharmaceuticals USA Inc h...
IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers
21 May 2020 - - Australian biomedical research organisation the Walter and Eliza Hall Institute of Medical Research has selected US-based IQVIA (NYSE: IQV) to manage COVID SHIELD, a Phase II/III ...
Rising Pharmaceuticals to Support Phase 2 Clinical Trial of Chloroquine Phosphate for Prophylaxis Against COVID-19 in Healthcare Workers at Risk for COVID-19
21 May 2020 - - US-based pharmaceutical company Rising Pharma Holdings Inc will support a Phase 2 clinical trial designed to determine the clinical efficacy of chloroquine phosphate in preventing coro...
Nivagen Pharmaceuticals Closes USD 16m Growth Equity Financing from Telegraph Hill Partners
20 May 2020 - - US-based specialty pharmaceuticals company Nivagen Pharmaceuticals, Inc has a USD 16m equity financing round led by life science venture capital and growth equity firm Telegraph Hill P...
Related Headlines

Hetero Enters Into a Licensing Agreement with Gilead for the Manufacturing and Distribution of "Remdesivir" in 127 Countries for COVID-19

Natera announces receipt of positive Medicare coverage for Prospera DNA test

Rising Pharmaceuticals, Laurus Labs to Support a Phase 2 Randomized Clinical Trial of Hydroxychloroquine for Prophylaxis Against COVID-19 in Patients Receiving Cancer Therapy

Lannett Company reports third quarter fiscal 2020 financial results

Henlius receives EU GMP certificate for HLX02

CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug "Avigan Tablet" and Contributes to Accelerating Provision for COVID-19 Patients

Kaneka Corporation signs contract with FUJIFILM Corporation to provide Avigan Tablet to treat COVID-19

Fujifilm expands production of influenza antiviral drug Avigan for COVID-19

USFDA grants final approval to Cipla's Albuterol Sulfate Inhalation Aerosol

FDA approves generic albuterol inhaler for treating bronchospasm

Perrigo announces FDA approval of store brand equivalent of Voltaren Arthritis Pain product and upcoming launch later this year

Hikma receives favourable ruling in generic Vascepa patent suit from US Court

Flexipharm Austrading unveils first vial and generic Methylthioninium Chloride for NHS hospitals

Cipla announces final approval for generic Nexium in 10mg, 20mg and 40mg; First to file for the 10mg strength

Mylan voluntarily waives exclusive rights to distribute generic version of Kaletra antiretroviral to aid US COVID-19 efforts